synthetic biology

Ellen: from board member to CEO and listing a company

Jane was CEO of Ellen October 2005 – December 2007. During this time, she listed the company on First North, did three rounds of financing, contracted the first three international distributors after her predecessor had contracted the first distributor in Sweden, changed production partner, and managed the end phases of R&D and the production implementation of new packaging with two year shelf life. She also managed a clinical trial in cooperation with Danderyds Hospital, and implemented ISO 13485 certification.

Article in Dagens Industri "Hon byter IT mot bioteknik"